F3685

Fibroblast Growth Factor-Basic, human

Name: Fibroblast Growth Factor-Basic, human
Brand: SIGMA

≥97% (SDS-PAGE), recombinant, expressed in E. coli, carrier free, suitable for cell culture

Synonim(y):

FGB-b, FGF-2, HBGF-2, HBGH-2, Prostatropin, bFGF

Slide 1 of 2

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Informacje o cenach i dostępności nie są obecnie dostępne.

Informacje o tej pozycji

UNSPSC Code:

12352202

NACRES:

NA.77

Biological source:

human

Recombinant:

expressed in E. coli

Assay:

≥97% (SDS-PAGE)

Form:

lyophilized powder

Mol wt:

16.0 kDa

Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

Pomoc techniczna

Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.

Pozwól nam pomóc

Nazwa produktu

Fibroblast Growth Factor-Basic, FGF-Basic, from human, recombinant, expressed in E. coli, carrier free

biological source

human

recombinant

expressed in E. coli

assay

≥97% (SDS-PAGE)

form

lyophilized powder

potency

<1 ng/mL Biological Activity EC₅₀

mol wt

16.0 kDa

packaging

pkg of 4X25 μg, pkg of 25 μg

storage condition

avoid repeated freeze/thaw cycles

color

white to faint yellow cast

solubility

water: soluble 0.025 mg, clear, colorless to faintly yellow

UniProt accession no.

P09038

storage temp.

−20°C

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 4

Ta pozycja	F5392	F5542	F3133
Sigma-Aldrich F3685 Fibroblast Growth Factor-Basic	Sigma-Aldrich F5392 Fibroblast Growth Factor-Basic from bovine pituitary	Sigma-Aldrich F5542 Fibroblast Growth Factor-Acidic human	Sigma-Aldrich F3133 Fibroblast Growth Factor from bovine pituitary
recombinant expressed in E. coli	recombinant -	recombinant expressed in E. coli	recombinant -
assay ≥97% (SDS-PAGE)	assay ~90% (SDS-PAGE and N-terminal analysis)	assay ≥97% (SDS-PAGE)	assay -
biological source human	biological source bovine pituitary glands	biological source human	biological source bovine pituitary glands
Quality Level 200	Quality Level 200	Quality Level 200	Quality Level 200
form lyophilized powder	form lyophilized powder	form lyophilized powder	form lyophilized powder
packaging pkg of 4X25 μg, pkg of 25 μg	packaging pkg of 1 μg	packaging pkg of 25 μg	packaging pkg of 10 and 5X10 μg

General description

Since FGF-Basic is found in a variety of organs, acts on a wide range of cell types, and has multifunctional actions, it has acquired numerous synonyms, including heparin-binding growth factor (class II or beta), eye-derived growth factor I, cartilage-derived growth factor, and astroglial growth factor II⁵. Purified bovine and human FGF-basic differ by 3 amino acids in sequence³, and are biologically and immunologically cross-reactive.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Klasa składowania

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

Nie widzisz odpowiedniej wersji?

Jeśli potrzebujesz konkretnej wersji, możesz wyszukać konkretny certyfikat według numeru partii lub serii.

Wyszukaj dokument COA

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Biobased Elastomer Nanofibers Guide Light-Controlled Human-iPSC-Derived Skeletal Myofibers.

Aimee Cheesbrough et al.

Advanced materials (Deerfield Beach, Fla.), 34(18), e2110441-e2110441 (2022-03-02)

Generating skeletal muscle tissue that mimics the cellular alignment, maturation, and function of native skeletal muscle is an ongoing challenge in disease modeling and regenerative therapies. Skeletal muscle cultures require extracellular guidance and mechanical support to stabilize contractile myofibers. Existing

Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma.

Marta E Capala et al.

Cancers, 15(2) (2023-01-22)

Head and neck squamous cell carcinoma (HNSCC) displays a large heterogeneity in treatment response, and consequently in patient prognosis. Despite extensive efforts, no clinically validated model is available to predict tumor response. Here we describe a functional test for predicting

Unraveling the disease pathogenesis behind lethal hydrolethalus syndrome revealed multiple changes in molecular and cellular level.

Heli Honkala et al.

PathoGenetics, 2(1), 2-2 (2009-04-30)

Hydrolethalus syndrome (HLS) is a severe fetal malformation syndrome characterized by multiple developmental anomalies, including central nervous system (CNS) malformation such as hydrocephaly and absent midline structures of the brain, micrognathia, defective lobation of the lungs and polydactyly. Microscopically, immature

SOX2-positive retinal stem cells are identified in adult human pars plicata by single-cell transcriptomic analyses.

Xiaotang Wang et al.

MedComm, 4(1), e198-e198 (2022-12-31)

Stem cell therapy is a promising strategy to rescue visual impairment caused by retinal degeneration. Previous studies have proposed controversial theories about whether in situ retinal stem cells (RSCs) are present in adult human eye tissue. Single-cell RNA sequencing (scRNA-seq)

Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia.

Parash Parajuli et al.

Developmental cell, 45(6), 712-725 (2018-06-20)

Cancer cachexia is characterized by extreme skeletal muscle loss that results in high morbidity and mortality. The incidence of cachexia varies among tumor types, being lowest in sarcomas, whereas 90% of pancreatic ductal adenocarcinoma (PDAC) patients experience severe weight loss.

Wyświetl wszystkie powiązane dokumenty

Powiązane treści

Data Sheet - F3685

Instructions

Questions

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej